Phase 2 Anemia, Sickle Cell Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Healthy VolunteersAnemia, Sickle Cell
Bristol-Myers Squibb184 enrolled19 locationsNCT06481306
Recruiting
Phase 1Phase 2
A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc.9 enrolled2 locationsNCT06144749
Recruiting
Phase 2
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
Anemia, Sickle Cell
Children's Hospital Medical Center, Cincinnati310 enrolled4 locationsNCT06290401